603 related articles for article (PubMed ID: 12735212)
21. [Treatment with cyclosporin A of the anemia associated with chronic lymphatic leukemia].
Rozman M; Montserrat E; Cervantes F; Bladé J; Marín P; Rozman C
Sangre (Barc); 1990 Aug; 35(4):321-5. PubMed ID: 2148838
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin and renal failure.
Macdougall IC
Curr Hematol Rep; 2003 Nov; 2(6):459-64. PubMed ID: 14561389
[TBL] [Abstract][Full Text] [Related]
23. Downstaging Rai stage III B-chronic lymphocytic leukemia patients with the administration of recombinant human erythropoietin.
Pangalis GA; Siakantaris MP; Angelopoulou MK; Vassilakopoulos TP; Dimopoulou MN; Kyrtsonis MC; Konstantopoulos K; Tsaftaridis P; Vaiopoulos GA; Kontopidou FN
Haematologica; 2002 May; 87(5):500-6. PubMed ID: 12010663
[TBL] [Abstract][Full Text] [Related]
24. The role of recombinant human erythropoietin in the management of anaemic cancer patients: focus on haematological malignancies.
Osterbor A
Med Oncol; 2000 Nov; 17 Suppl 1():S17-22. PubMed ID: 11188781
[TBL] [Abstract][Full Text] [Related]
25. [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
Monnerat C; Leyvraz S
Praxis (Bern 1994); 1999 Jan; 88(5):178-88. PubMed ID: 10067375
[TBL] [Abstract][Full Text] [Related]
26. [Erythropoietin].
Kubanek B; Rich I; Noé G
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():46-50. PubMed ID: 7531047
[TBL] [Abstract][Full Text] [Related]
27. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial.
Auerbach M; Ballard H; Trout JR; McIlwain M; Ackerman A; Bahrain H; Balan S; Barker L; Rana J
J Clin Oncol; 2004 Apr; 22(7):1301-7. PubMed ID: 15051778
[TBL] [Abstract][Full Text] [Related]
28. Risks and benefits of erythropoiesis-stimulating agents in cancer management.
Beutel G; Ganser A
Semin Hematol; 2007 Jul; 44(3):157-65. PubMed ID: 17631180
[TBL] [Abstract][Full Text] [Related]
29. Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, Phase III, randomized, double-blind, placebo-controlled study.
Tsuboi M; Ezaki K; Tobinai K; Ohashi Y; Saijo N
Jpn J Clin Oncol; 2009 Mar; 39(3):163-8. PubMed ID: 19164318
[TBL] [Abstract][Full Text] [Related]
30. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
Wang W; Zhang MH; Yu Y; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
[TBL] [Abstract][Full Text] [Related]
31. The impact and management of anaemia in haematological malignancies.
Coiffier B
Med Oncol; 2000 Nov; 17 Suppl 1():S2-10. PubMed ID: 11188782
[TBL] [Abstract][Full Text] [Related]
32. Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model.
Woodburn KW; Fan Q; Winslow S; Chen MJ; Mortensen RB; Casadevall N; Stead RB; Schatz PJ
Exp Hematol; 2007 Aug; 35(8):1201-8. PubMed ID: 17662888
[TBL] [Abstract][Full Text] [Related]
33. Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients.
Beguin Y
Haematologica; 2002 Nov; 87(11):1209-21. PubMed ID: 12414352
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
[TBL] [Abstract][Full Text] [Related]
35. In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.
Zwierzina H; Bammer T; Rollinger-Holzinger I; Herold M; Fenaux P; Nüssler V; Hoflehner E; Geissler D
Clin Cancer Res; 1996 Jun; 2(6):1031-8. PubMed ID: 9816264
[TBL] [Abstract][Full Text] [Related]
36. Recombinant human erythropoietin in combined treatment with granulocyte- or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.
Kasper C; Zahner J; Sayer HG
J Cancer Res Clin Oncol; 2002 Sep; 128(9):497-502. PubMed ID: 12242514
[TBL] [Abstract][Full Text] [Related]
37. The role of recombinant human erythropoietin alpha in the treatment of chronic anemia in multiple myeloma.
Dammacco F; Luccarelli G; Prete M; Silvestris F
Rev Clin Exp Hematol; 2002; Suppl 1():32-8. PubMed ID: 12735213
[TBL] [Abstract][Full Text] [Related]
38. Preclinical and clinical effects of erythropoietin in the management of anaemia in patients with non-small cell lung cancer.
Dempke W
Anticancer Res; 2007; 27(4A):1745-57. PubMed ID: 17649769
[TBL] [Abstract][Full Text] [Related]
39. rHuEPO and improved treatment outcomes: potential modes of action.
Blackwell K; Gascón P; Sigounas G; Jolliffe L
Oncologist; 2004; 9 Suppl 5():41-7. PubMed ID: 15591421
[TBL] [Abstract][Full Text] [Related]
40. [Pure red-cell anemia due to recombinant human erythropoietin and its status in oncology practice].
Lehoczky O
Magy Onkol; 2004; 48(2):163-6. PubMed ID: 15351813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]